BOTHELL, Wash. and COPENHAGEN, Denmark and BERKELEY, Calif. and TOKYO, Dec. 20, 2016 /PRNewswire/ — CMC Biologics, a global leader in clinical and commercial manufacturing of monoclonal antibodies, ...

CMC Biologics, a global leader in clinical and commercial manufacturing of therapeutic proteins, and River Vision Development Corporation (River Vision), a private company focused on ophthalmology, ...

Complete insights on biologic CMC requirements enable pharma, biotech and generics organizations to accelerate innovation by bringing life-saving medicines to ...

SOUTH SAN FRANCISCO, Calif. and SEATTLE, March 12 /PRNewswire/ -- Raven biotechnologies, inc., a privately held company focused on the discovery and development of monoclonal antibody therapeutics ...

According to Gustavo F. Mahler, Ph.D., Global Chief Operations Officer of CMC Biologics, "The expansion of the facility to include the 2,000L SUB will allow us to meet increasing demand for producing ...

CMC ICOS Biologics, a global leader in clinical and commercial manufacturing of therapeutic proteins, and Harpoon Therapeutics, an immuno-oncology company using a proprietary TriTAC technology ...

Recognized as Biologics CDMO of the Year, BioDlink shares insights into the world's first approved EGFR-targeted ADC for recurrent/metastatic nasopharyngeal carcinoma The company enables seamless ...

CMC Biologics has announced the acquisition of XOMA Corporation’s large-scale manufacturing operations and affiliated assets located in Berkeley, California. Financial terms of the transaction were ...

Discussion to Cover the Importance of Early-Stage CMC Testing in Enhancing Biologic Predictability, Scaling Up, and Accelerating Time to Market KAISERAUGST, Switzerland, April 22, 2025 /PRNewswire/ -- ...

Complete insights on biologic CMC requirements enable pharma, biotech and generics organizations to accelerate innovation by bringing life-saving medicines to ...